Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

A double-blind randomised crossover trial of low-dose flumazenil for benzodiazepine withdrawal: A proof of concept

BZDs are often a difficult drug class to cease once neuroadaptation has occurred; recommendations usually involve gradual dose reductions of variable rates.

Original research | 2022
Withdrawal, Clinical guidance

Diagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Review

Guidelines | 2022
Clinical guidance, About prescribers, Injecting drugs

Guidance Document on the Management of Substance Use in Acute Care

Guidelines | 2020
Clinical guidance, Advocacy, Barriers and enablers, Hospitals, About prescribers

Fair Price Pharma Inhalation Diacetylmorphine Operational Guide

Guide or handbook | 2022
Safer supply, Clinical guidance, About prescribers

Case report: acute care management of severe opioid withdrawal with IV fentanyl

Case study | 2022
Clinical guidance, Hospitals, About prescribers, Barriers and enablers, Outcomes

Clinical management of withdrawal from benzodiazepine anxiolytic and hypnotic medications

Guidelines | 2021
Withdrawal, Clinical guidance, About prescribers

Best Practice Guidelines: Implementing Supervised Injection Services

Guidelines | 2018
SCS/OPS, Clinical guidance, Harm reduction, Social services, Illegal drugs

Échelle du Sevrage Clinique des Opioïdes

Formulaire de sélection/d’évaluation | 2022
à propos des personnes qui utilisent des drogues, à propos des prescripteurs, les guides de pratique clinique, le sevrage, l'équité

French-Canadian Translation and Cultural Adaptation of the Clinical Opiate Withdrawal Scale: The COWS-FC

The Clinical Opiate Withdrawal Scale (COWS) is a validated, clinician-administered instrument initially developed and validated for English-speaking populations.

Original research | 2022
Clinical guidance, Equity, Withdrawal, About prescribers

Recommendations for the provision of opioid agonist therapy in publicly funded residential addiction treatment centres in Ontario

Guide or handbook | 2022
Substitution/OAT, Clinical guidance, Policy/Regulatory, Wrap-around services, About prescribers, Hesitancy of prescribers , Transitions in care/treatment

Six Moments of Infection Prevention in Injection Drug Use: An Educational Toolkit for Clinicians

The “Six Moments of Infection Prevention in Injection Drug Use” provider educational tool was developed using a global, rather than pathogen-specific, infection prevention framework, highlighting t

Original research | 2022
About prescribers, Harm reduction, Clinical guidance, Safer supply, Injecting drugs

Best Practice Recommendations for Canadian Programs That Provide Harm Reduction Supplies to People Who Use Drugs and are At Risk for HIV, HCV, and Other Harms: 2021

The goal of the Best Practice Recommendations is to improve the effectiveness of programs that deliver harm reduction supplies to people who use drugs and are at risk for human immunodeficiency virus
Guide or handbook | 2021
Clinical guidance, Harm reduction, Policy/Regulatory, Wrap-around services, About prescribers, Illegal drugs, Injecting drugs

Making Addiction Treatment More Realistic And Pragmatic: The Perfect Should Not Be The Enemy Of The Good

Commentary | 2022
Overdose, Clinical guidance, Harm reduction, Policy/Regulatory, Hesitancy of prescribers , About prescribers, Illegal drugs, SCS/OPS

Cost-Effectiveness and Guidelines for Opioid Substitution Treatment

Examine the cost-effectiveness of SROM, hydromorphone, diacetylmorphine, and fentanyl in opioid use disorder, and describe the evidence-based guidelines for the use of these treatments
Lit review | 2021
Clinical guidance, Evidence base, Safer supply, About prescribers, Substitution/OAT

Wound Bed Preparation 2021

To present the 2021 update of the Wound Bed Preparation paradigm
Guidelines | 2021
Clinical guidance, Wrap-around services, About prescribers, Chronic pain, Injecting drugs

Boîte à outils pour la mise en place d’un site répondant à un besoin urgent en matière de santé publique (SBUSP)

Guide or handbook | 2021
Overdose, Clinical guidance, Harm reduction, About prescribers, Social services, Illegal drugs, SCS/OPS

Trauma Informed Practice and the Opioid Crisis: A Discussion Guide for Health Care and Social Service Providers

Research has shown that the vast majority of individuals who experience problems with opioid misuse and addiction have current or past experiences of trauma and violence.
Guide or handbook | 2018
Clinical guidance, Harm reduction, Sex/Gender , Mental health

Treatment Approaches for Users of Methamphetamine: A Practical Guide for Frontline Workers

Alcohol and other drug (AOD) workers from a variety of service settings are now frequently required to respond to methamphetamine users who are experiencing the harmful effects of methamphetamine, goi
Guide or handbook | 2008
Clinical guidance, Harm reduction, About prescribers, Social services, Illegal drugs, Stimulants, Transitions in care/treatment

Québec Guide to Improving Practices in the Management of Opioid Use Disorder

Guidelines | 2020
Clinical guidance, Harm reduction, Safer supply, About prescribers, Substitution/OAT, Transitions in care/treatment

Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study

The aim of this work was to understand (1) the perspectives of family physicians (FPs) as it relates to opioid prescribing, and (2) the perceived barriers and enablers to guideline-adherent opioid pre
Original research | 2019
Clinical guidance, Policy/Regulatory, Hesitancy of prescribers , Safer supply, About prescribers, Barriers and enablers, Chronic pain

Refine Your Search

Keywords
Format
Region